Literature DB >> 21660445

Serotonin-2A receptor regulation of panic-like behavior in the rat dorsal periaqueductal gray matter: the role of GABA.

Thatiane de Oliveira Sergio1, Valquiria Camin de Bortoli, Helio Zangrossi.   

Abstract

RATIONALE: Electrical stimulation of the dorsal periaqueductal gray (dPAG) evokes escape, a defensive response associated with panic attacks. Stimulation of 5-HT1A or 5-HT2A receptors in this midbrain area equally inhibits escape performance, even though at the molecular level these receptors cause opposite effects, i.e., activation of the former hyperpolarizes the cell membrane, while the latter excites it. A proposal has been made that 5-HT2A receptor agonists exert their inhibitory effect on escape by activating GABAergic interneurons located in the dPAG.
OBJECTIVES: In the present study, we evaluated this hypothesis by investigating whether previous intra-dPAG administration of the GABAA receptor antagonist bicuculline blocks the anti-escape effect caused by the local injection of different 5-HT2A/2C receptor agonists.
RESULTS: Intra-dPAG administration of 5-HT, the preferential 5-HT2A receptor agonist DOI, the nonselective 5-HT2C receptor agonist mCPP or the 5-HT2C receptor agonist RO 60-0175 significantly inhibited the escape reaction induced by electrical stimulation of the same brain area. In all cases, this panicolytic-like effect was blocked by previous microinjection of bicuculline. This GABAA antagonist, however, failed to antagonize the anti-escape effect caused by the 5-HT1A receptor agonist 8-OH-DPAT. The inhibitory effect caused by DOI, RO 60-0175, and mCPP was also blocked by previous intra-dPAG injection of the preferential 5-HT2A receptor antagonist ketanserin. Pre-administration of the 5-HT2C receptor antagonist SB-242084 in the dPAG did not block the anti-escape effect of RO 60-0175.
CONCLUSIONS: Stimulation of 5-HT2A but not 5-HT2C receptors in the dPAG causes a panicolytic-like effect that is mediated by facilitation of GABAergic neurotransmission.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21660445     DOI: 10.1007/s00213-011-2369-2

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  40 in total

1.  Cells related to fighting behavior recorded from midbrain central gray neuropil of cat.

Authors:  D B Adams
Journal:  Science       Date:  1968-02-23       Impact factor: 47.728

2.  Chronic imipramine treatment sensitizes 5-HT1A and 5-HT 2 A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety.

Authors:  J M Zanoveli; R L Nogueira; H Zangrossi
Journal:  Behav Pharmacol       Date:  2005-11       Impact factor: 2.293

3.  5-HT2C receptor regulation of defensive responses in the rat dorsal periaqueductal gray.

Authors:  Paula Shimene de Melo Yamashita; Valquiria Camin de Bortoli; Helio Zangrossi
Journal:  Neuropharmacology       Date:  2010-09-17       Impact factor: 5.250

4.  When fear is near: threat imminence elicits prefrontal-periaqueductal gray shifts in humans.

Authors:  Dean Mobbs; Predrag Petrovic; Jennifer L Marchant; Demis Hassabis; Nikolaus Weiskopf; Ben Seymour; Raymond J Dolan; Christopher D Frith
Journal:  Science       Date:  2007-08-24       Impact factor: 47.728

5.  Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze.

Authors:  Selma Conceição Poltronieri; Hélio Zangrossi; Milena de Barros Viana
Journal:  Behav Brain Res       Date:  2003-12-17       Impact factor: 3.332

6.  Alprazolam potentiates the antiaversive effect induced by the activation of 5-HT(1A) and 5-HT (2A) receptors in the rat dorsal periaqueductal gray.

Authors:  Valquíria Camin de Bortoli; Regina Lúcia Nogueira; Hélio Zangrossi
Journal:  Psychopharmacology (Berl)       Date:  2008-04-30       Impact factor: 4.530

Review 7.  Serotonin, the periaqueductal gray and panic.

Authors:  Frederico G Graeff
Journal:  Neurosci Biobehav Rev       Date:  2004-05       Impact factor: 8.989

8.  Panicolytic-like effect of BDNF in the rat dorsal periaqueductal grey matter: the role of 5-HT and GABA.

Authors:  Plínio Cabrera Casarotto; Valquiria Camin de Bortoli; Fernando Morgan de Aguiar Corrêa; Leonardo Barbosa Moraes Resstel; Hélio Zangrossi
Journal:  Int J Neuropsychopharmacol       Date:  2010-01-05       Impact factor: 5.176

9.  Chronic imipramine enhances 5-HT(1A) and 5-HT(2) receptors-mediated inhibition of panic-like behavior in the rat dorsal periaqueductal gray.

Authors:  Cláudia A Jacob; Alfredo H C L Cabral; Leandro P Almeida; Valeska Magierek; Patrício L Ramos; Janaína M Zanoveli; Jesus Landeira-Fernandez; Hélio Zangrossi; Regina L Nogueira
Journal:  Pharmacol Biochem Behav       Date:  2002-07       Impact factor: 3.533

Review 10.  Panic disorder: is the PAG involved?

Authors:  Cristina Marta Del-Ben; Frederico Guilherme Graeff
Journal:  Neural Plast       Date:  2009-03-10       Impact factor: 3.599

View more
  5 in total

1.  Periaqueductal gray matter modulates the hypercapnic ventilatory response.

Authors:  Luana T Lopes; Luis G A Patrone; Kênia C Bícego; Norberto C Coimbra; Luciane H Gargaglioni
Journal:  Pflugers Arch       Date:  2012-06-05       Impact factor: 3.657

Review 2.  The Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic.

Authors:  Evan D Paul; Philip L Johnson; Anantha Shekhar; Christopher A Lowry
Journal:  Neurosci Biobehav Rev       Date:  2014-03-21       Impact factor: 8.989

3.  Effect of genetic and pharmacological blockade of GABA receptors on the 5-HT2C receptor function during stress.

Authors:  Cédric B P Martin; Martin Gassmann; Caroline Chevarin; Michel Hamon; Uwe Rudolph; Bernhard Bettler; Laurence Lanfumey; Raymond Mongeau
Journal:  J Neurochem       Date:  2014-09-04       Impact factor: 5.372

Review 4.  Animal models of serotonergic psychedelics.

Authors:  James B Hanks; Javier González-Maeso
Journal:  ACS Chem Neurosci       Date:  2012-09-24       Impact factor: 4.418

Review 5.  Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?

Authors:  Bruno P Guiard; Giuseppe Di Giovanni
Journal:  Front Pharmacol       Date:  2015-03-17       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.